Jay R. Venkatesan - 19 May 2025 Form 4 Insider Report for Elicio Therapeutics, Inc. (ELTX)

Role: Director
Signature: /s/ Jay Venkatesan
Issuer symbol: ELTX
Transactions as of: 19 May 2025
Net transactions value: $0
Form type: 4
Filing time: 20 May 2025, 16:07:13 UTC
Previous filing: 10 Apr 2025
Next filing: 10 Nov 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Venkatesan Jay	Director	C/O ELICIO THERAPEUTICS, INC., 451 D STREET, 5TH FLOOR, SUITE 501, BOSTON	/s/ Jay Venkatesan	20 May 2025	0001413350

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELTX	Stock Option (Right to Buy)	Award	$0	+7,900		$0.000000	7,900	19 May 2025	Common Stock	7,900	$5.84	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock option shall vest and become exercisable in full on the earlier of (A) May 19, 2026, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after the grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date.